帕金森病的诊断与治疗简介(华中科技大学同济医学院 协和医院 曹学兵)_.pptVIP

47-1 除了PD的起始治疗指南（AAN）为2002年发布外，其他3个指南均为2006年发布 FIG. 1. Time course of the overall abnormal involuntary movements (AIMs) development on day 1 (A) and day 22 (B) for each group of treatment. **P ﹤ 0.01 vs. saline; #P ﹤ 0.05, ##P ﹤ 0.01 vs. L-dopa plus entacapone; one way analysis of variance followed by Dunnett’s t test 恩他卡朋在人群中是否能够减少异动症的发生，目前正在试验之中 Stalevo Reduction In Dyskinesia Evaluation: STRIDE-PD Primary objective: To demonstrate that Stalevo is superior to carbidopa/levodopa in time to onset of dyskinesia in Parkinson’s disease patients requiring initiation of levodopa treatment w